鹿得医疗
(920278)
| 流通市值：6.09亿 | | | 总市值：10.77亿 |
| 流通股本：9864.53万 | | | 总股本：1.75亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 147,905,317.35 | 61,690,963.34 | 300,094,980.3 | 216,474,324.02 |
| 营业总成本 | 148,651,204.57 | 64,342,817.65 | 286,397,898.4 | 201,297,903.75 |
| 其他经营收益 | | | | |
| 营业利润 | 2,786,020.28 | 370,638.03 | 20,974,221.78 | 19,593,528.65 |
| 利润总额 | 2,728,694.29 | 356,269.78 | 20,740,051.49 | 19,366,197.51 |
| 净利润 | 3,457,248.32 | 667,289 | 19,220,537 | 17,506,250.08 |
| 每股收益 | | | | |
| 其他综合收益 | -1,682.28 | -1,114.68 | -1,534.51 | -794.42 |
| 综合收益总额 | 3,455,566.04 | 666,174.32 | 19,219,002.49 | 17,505,455.66 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 301,070,625.42 | 311,232,677.87 | 351,289,009.79 | 338,495,546.82 |
| 非流动资产: | | | | |
| 非流动资产合计 | 259,448,250.48 | 260,706,519.4 | 253,381,579.54 | 234,994,610.4 |
| 资产总计 | 560,518,875.9 | 571,939,197.27 | 604,670,589.33 | 573,490,157.22 |
| 流动负债: | | | | |
| 流动负债合计 | 166,956,808.44 | 180,385,554.71 | 216,916,494.3 | 187,400,114.91 |
| 非流动负债: | | | | |
| 非流动负债合计 | 5,952,745.99 | 6,350,544.47 | 3,217,171.26 | 3,284,082.76 |
| 负债合计 | 172,909,554.43 | 186,736,099.18 | 220,133,665.56 | 190,684,197.67 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 387,489,830.56 | 385,014,197.43 | 384,334,837.52 | 382,550,737.66 |
| 股东权益合计 | 387,609,321.47 | 385,203,098.09 | 384,536,923.77 | 382,805,959.55 |
| 负债和股东权益合计 | 560,518,875.9 | 571,939,197.27 | 604,670,589.33 | 573,490,157.22 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 144,923,809.01 | 75,965,738.67 | 456,674,280.45 | 362,533,770.22 |
| 经营活动现金流出小计 | 169,299,832.97 | 82,584,113.41 | 303,499,934.38 | 230,275,609.12 |
| 经营活动产生的现金流量净额 | -24,376,023.96 | -6,618,374.74 | 153,174,346.07 | 132,258,161.1 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 783,220,945.46 | 485,987,868.57 | 810,750,208.5 | 503,761,608.56 |
| 投资活动现金流出小计 | 778,333,980.99 | 442,017,471.66 | 940,024,078.44 | 619,638,469.41 |
| 投资活动产生的现金流量净额 | 4,886,964.47 | 43,970,396.91 | -129,273,869.94 | -115,876,860.85 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 39,500,000 | 29,500,000 | 54,917,417.39 | 68,989,173.8 |
| 筹资活动现金流出小计 | 45,222,161.07 | 35,293,816.07 | 67,255,996.61 | 76,239,874 |
| 筹资活动产生的现金流量净额 | -5,722,161.07 | -5,793,816.07 | -12,338,579.22 | -7,250,700.2 |
| 汇率变动对现金及现金等价物的影响 | -1,154,040.58 | -701,590.38 | -778,854.33 | 730,153.54 |
| 现金及现金等价物净增加额 | -26,365,261.14 | 30,856,615.72 | 10,783,042.58 | 9,860,753.59 |
| 期末现金及现金等价物余额 | 113,299,903.53 | 170,521,780.39 | 139,665,164.67 | 138,742,875.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -26,365,261.14 | - | 10,783,042.58 | - |